1,3-Diethyl 2-oxopropanedioate → ethyl 3,4-dihydro-7-[1-(1H-imidazol-1-yl)-2-methylpropyl]3-oxo-2-quinoxalinecarboxylate
Reaction equation
[N:1]1([CH:6]([C:10]2[CH:11]=[C:12]([NH2:17])[C:13]([NH2:16])=[CH:14][CH:15]=2)[CH:7]([CH3:9])[CH3:8])[CH:5]=[CH:4][N:3]=[CH:2]1.O=[C:19]([C:25](OCC)=[O:26])[C:20]([O:22][CH2:23][CH3:24])=[O:21]>C(O)C>[N:1]1([CH:6]([C:10]2[CH:11]=[C:12]3[C:13]([NH:16][C:25](=[O:26])[C:19]([C:20]([O:22][CH2:23][CH3:24])=[O:21])=[N:17]3)=[CH:14][CH:15]=2)[CH:7]([CH3:8])[CH3:9])[CH:5]=[CH:4][N:3]=[CH:2]1Participants
4
Procedure
A solution of 15 parts of 4-[1-(1H-imidazol-1-yl)-2-methylpropyl]-1,2-benzenediamine and 12.5 parts of diethyl 2-oxo-1,3-propanedioate in 80 parts of ethanol was stirred for 2 hours at reflux temperature. The reaction mixture was evaporated and the residue was purified by column chromatography over silica gel using a mixture of dichloromethane and methanol (95:5 by volume) as eluent. The pure fractions were collected and the eluent was evaporated. The residue was crystallized from a mixture of acetonitrile and ethanol. The product was filtered off and dried, yielding 3.1 parts (14.0%) of ethyl 3,4-dihydro-7-[1-(1H-imidazol-1-yl)-2-methylpropyl]-3-oxo-2-quinoxalinecarboxylate; mp. 229.7° C. (comp. 107).
Workup
- temperatureat reflux temperature
- customThe reaction mixture was evaporated
- customthe residue was purified by column chromatography over silica gel using
- additiona mixture of dichloromethane and methanol (95:5 by volume) as eluent
- customThe pure fractions were collected
- customthe eluent was evaporated
- customThe residue was crystallized from a mixture of acetonitrile and ethanol
- filtrationThe product was filtered off
- customdried
Sources & evidence
- ORD record
- ord-ca710a691f064426b163012343375a21
- Source dataset
- uspto-grants-1991_07
- Patent number
- US05028606
Reaction notes
Loading…